[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368477-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368477-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","new-spirooxindole-pyrrolidinepyrrolizidine-analogs-design-synthesis-and-evaluation-as-an-anticancer-agent","New spirooxindole pyrrolidine/pyrrolizidine analogs - design, synthesis, and evaluation as an anticancer agent","","A novel series of mesitylene-based spirooxindoles was synthesized through a multicomponent [3 + 2] cycloaddition in a greener medium. Structural characterization was performed using 1H and 13C NMR together with HRMS. In vitro studies assessed cytotoxicity of the spirooxindole analogs (4/5a–g) against human lung cancer A549 cells, revealing seven more potent compounds among fourteen total. Selected compounds were also tested against non-cancerous NIH-3T3 cells, with apoptosis confirmed by Hoechst and acridine orange/ethidium bromide staining, indicating reduced proliferation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/new-spirooxindole-pyrrolidinepyrrolizidine-analogs-design-synthesis-and-evaluation-as-an-anticancer-agent/368477/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/new-spirooxindole-pyrrolidinepyrrolizidine-analogs-design-synthesis-and-evaluation-as-an-anticancer-agent/368477.png","ImageObject",300,407,{"name":42,"@type":43},"Sophia Brooks","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-21","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were the mesitylene-based spirooxindole analogs synthesized?","Question",{"text":63,"@type":64},"They were synthesized via a multicomponent [3 + 2] cycloaddition reaction in a greener medium.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cancer cells were used to evaluate cytotoxicity, and what were the results?",{"text":68,"@type":64},"Cytotoxicity was tested against human lung cancer A549 cells, where seven compounds showed higher potency among fourteen synthesized analogs.",{"name":70,"@type":61,"acceptedAnswer":71},"How was apoptosis of potent compounds demonstrated?",{"text":72,"@type":64},"Apoptotic effects were evaluated using Hoechst and acridine orange/ethidium bromide staining, which corresponded to decreased cell proliferation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368477,1790217033,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","RSC Advances  \nPAPER  \nCite this: RSC Adv., 2025, 15, 16623  \nReceived 7th March 2025  \nAccepted 24th April 2025  \nDOI: 10.1039/d5ra01632k[rsc.li/rsc-advances](rsc.li/rsc-advances)  \nNew spirooxindole pyrrolidine/pyrrolizidine analogs: design, synthesis, and evaluation as an anticancer agent†  \nNarayanasamy Nivetha,a Janarthanan Venkatesan,b Dhanashree Murugan,b Loganathan Rangasamy, b Shu Pao Wuc and Sivan Velmathi  *a  \nA novel series of mesitylene-based spirooxindoles were synthesized via the multicomponent [3 + 2] cycloaddition reaction in a greener medium. Spectroscopic techniques such as 1 H and 13C NMR and HRMS analysis were carried out for the structural elucidation of all the spirooxindole derivatives. The in vitro cytotoxicity properties of spirooxindole analogs 4/5(a–g) against the human lung (A549) cancer cell line exhibited encouraging outcomes. Of the fourteen synthesized spirooxindole analogs, seven compounds (4a, 4b, 4e, 4g, 5c, 5e, and 5f) showed greater potency towards the A549 lung cancer cell line. The cytotoxicity of the spirooxindole analogs was also investigated against a non-cancerous mouse embryonic ﬁbroblast NIH-3T3 cell line. Compounds 5e and 5f, which exhibited better cytotoxic eﬀect against the cancerous A549 cells (3 .48 and 1 .2 mM), appeared to be non-cytotoxic against the noncancerous mouse embryonic ﬁbroblast. Studies using Hoechst and acridine orange/ethidium bromide staining also demonstrated the apoptotic eﬀect of the potent compounds, which decreased cell proliferation.  \nIntroduction  \nLung cancer poses a major threat to human health and is one of the most deadly and debilitating malignancies in the world.1,2 Nonetheless, the 5 year survival rate for lung cancer is less than 15%, and the death rate remains high.3 Over the past century, signi􀀁cant advancements in drug innovation regarding oral bioavailability and biological compatibility have been made; however, drug resistance has become a challenge for medicinal chemists. Consequently, pharmacologists and chemists are concentrating on the functional diversity of pharmacological leads,4 nano-formulation, and the advancement of drug delivery systems,5–7 with the objective of addressing current challenges. For this reason, it is crucial to 􀀁nd new therapeutic medications to treat lung cancer.  \nSpiroheterocyclic hybrids with pyrrolidine ring systems have been documented as an important class of potentially bioactive compounds that are frequently constructed via [3 + 2] cycloaddition of azomethine ylide8–10 and possess a wide range of  \naOrganic and Polymer Synthesis Laboratory, Department of Chemistry, National Institute of Technology, Tiruchirappalli, 620015, Tamil Nadu, India. E-mail: [velmathis@nitt.edu](velmathis@nitt.edu)  \nbDrug Discovery Unit, Centre for Biomaterials, Cellular and Molecular Theragnostic (CBCMT), Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India cDepartment of Applied Chemistry, National Yang Ming Chiao Tung University, Hsinchu, 30010, Taiwan, Republic of China  \n† Electronic supplementary information (ESI) available. See DOI:  \n[https://doi.org/10.1039/d5ra01632k](https://doi.org/10.1039/d5ra01632k)  \npharmacological activities.11–13 The spirooxindole scaﬀold is a unique structure made up of two fundamental subunits. Oxindole, the 􀀁rst subunit, has several functions and can interact with biological targets by hydrogen bonding as either donors or acceptors. A carbocyclic or heterocyclic moiety fused with an oxindole ring at the C-3 position makes up the second unit. In addition, hybridizing the spirooxindole nucleus with other moieties has led to the development of new molecules with enhanced anticancer activity pro􀀁les. Because of its facile synthesis and easily accessible reagents, azomethine ylide isone of the most useful reactive 1,3-dipoles in the [3 + 2] cycloaddition reaction.14,15 The most practical synthesis approach for functionalized spirooxindoles is the [3 + 2] cycloaddition of azomethin","cbCaif6YjmfPCWFy","https://ap.wps.com/l/cbCaif6YjmfPCWFy","pdf",1466594,12,"English","# Introduction\n## Synthesis and characterization\n## In vitro cytotoxicity evaluation\n## Non-cancerous cell selectivity\n## Apoptosis studies","[{\"question\":\"How were the mesitylene-based spirooxindole analogs synthesized?\",\"answer\":\"They were synthesized via a multicomponent [3 + 2] cycloaddition reaction in a greener medium.\"},{\"question\":\"Which cancer cells were used to evaluate cytotoxicity, and what were the results?\",\"answer\":\"Cytotoxicity was tested against human lung cancer A549 cells, where seven compounds showed higher potency among fourteen synthesized analogs.\"},{\"question\":\"How was apoptosis of potent compounds demonstrated?\",\"answer\":\"Apoptotic effects were evaluated using Hoechst and acridine orange/ethidium bromide staining, which corresponded to decreased cell proliferation.\"}]","New spirooxindole pyrrolidine/pyrrolizidine analogs - design, synthesis, and evaluation as an anticancer agent | PDF",1790177164,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8796c2b94eff4f919e7e0306217c7e21.webp",983,1287,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fc83c0f5ef9c6ae292e48f60c7a4375.webp",982,1286,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1b21ae67047249e16de57dc3430dbfe.webp",981,1284,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae1d6f6313b44467ac0ee4c4acc4c207.webp",980,1283]